Results 171 to 180 of about 1,086,070 (250)

Europe's failure to deliver on drug-resistant tuberculosis. [PDF]

open access: yesLancet Reg Health Eur
The Lancet Regional Health-Europe.
europepmc   +1 more source

Rare emergence of delamanid resistance in multidrug-/rifampicin-resistant tuberculosis patients receiving delamanid-containing regimens: a prospective multicentric study in China. [PDF]

open access: yesAnn Clin Microbiol Antimicrob
Shu W   +15 more
europepmc   +1 more source

Anaemia, hypoalbuminemia, and risk of cycloserine-associated neuropsychiatric toxicity in a shortened oral regimen for multidrug/rifampicin-resistant TB. [PDF]

open access: yesIJTLD Open
Shen EQL   +13 more
europepmc   +1 more source

Diagnostic Discordance During MDR-TB Treatment: Retrospective Identification of <i>Mycobacterium avium Complex</i>-Associated Nontuberculous Mycobacterium by Whole-Genome Sequencing. [PDF]

open access: yesMicroorganisms
Rukasha I   +9 more
europepmc   +1 more source

Burden of multidrug-resistant and extensively drug-resistant tuberculosis in China, India and Russia: estimates from the GBD 2023 study. [PDF]

open access: yesJ Thorac Dis
Li JD   +10 more
europepmc   +1 more source

Contezolid in the Treatment of Multidrug-Resistant Tuberculous Meningitis: A Case Report. [PDF]

open access: yesClin Case Rep
Wang N   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy